Taiwan’s approach to evaluating the efficacy of COVID-19 vaccine candidates has not been used by any other country as a basis for granting emergency use authorization (EUA), Minister of Health and Welfare Chen Shih-chung (陳時中) said on Friday.
During a legislative hearing, Taiwan People’s Party Legislator Ann Kao (高虹安) questioned Chen about review standards for issuing EUAs for domestic COVID-19 vaccines, which the Food and Drug Administration (FDA) published on Thursday.
While Taiwan’s domestically developed vaccine candidates have completed phase 1 and 2 clinical trials, none of them have begun larger phase 3 trials — which are typically the standard for determining efficacy. FDA guidelines allow EUAs to be issued without phase 3 trials, by instead analyzing phase 2 results through immunobridging, which uses the immune response measured in clinical trial participants to infer the overall level of protection a vaccine would provide.
Photo courtesy of the Kaohsiung City Government Department of Health via CNA
Critics say that this approach, which is based on the potency levels of neutralizing antibodies found in clinical trial participants, cannot be used to accurately determine a vaccine’s efficacy.
Kao asked Chen whether Taiwan would be the first country to grant an EUA using immunobridging as a substitute for efficacy data obtained in phase 3 clinical trials.
Initially, Chen said that he could not speak to the approaches being adopted by regulators in other countries, adding that immunobridging has been a topic of discussion in the WHO.
When pressed, Chen said that “there are currently no approvals of this type.”
“If that is the case, then this is genuinely frightening,” Kao said. “Taiwan has purchased 10 million [local] vaccines, enough to give to 5 million people.”
“If the efficacy of the domestic vaccines does not meet expectations, then these people are like the emperor with no clothes — completely without protection,” she said.
Russia and China have approved COVID-19 vaccines for use before they entered phase 3 trials or before efficacy data from those trials had been published, but Taiwan would be the first country to grant an EUA using the immunobridging approach, Chen said.
Debate on the FDA’s standards has grown, following Medigen Vaccine Biologics’ announcement on Thursday that it would soon apply for an EUA, after becoming the first local vaccine maker to “unblind” results of its phase 2 clinical trials.
The FDA’s review would compare the neutralizing antibody potency levels of Medigen trial participants with those from a control group of 200 recipients of the AstraZeneca vaccine in Taiwan, Chen said.
As data from the AstraZeneca group is pending, the EUA review would likely begin later this month, Chen said, adding that there would be no pressure on the FDA and no deadline for when it should be completed.
In a follow-up question, Kao said that the US Food and Drug Administration had publicly broadcast its EUA review meetings for the Moderna COVID-19 vaccine, and asked Chen if Taiwan would be willing to do the same.
Chen said that he would respect whatever decision the vaccine review committee made on the matter, but added that there are no plans to broadcast the proceedings.
If Medigen’s vaccine is granted an EUA and if plans to use immunobridging, with phase 3 trials to be conducted later, gain traction internationally, the vaccine would have a chance of being approved by the WHO, Chen said.
Even without international recognition, Taiwanese would not be prohibited from entering other countries based on what vaccine they receive, although quarantine procedures might differ, he added.
The military has spotted two Chinese warships operating in waters near Penghu County in the Taiwan Strait and sent its own naval and air forces to monitor the vessels, the Ministry of National Defense (MND) said. Beijing sends warships and warplanes into the waters and skies around Taiwan on an almost daily basis, drawing condemnation from Taipei. While the ministry offers daily updates on the locations of Chinese military aircraft, it only rarely gives details of where Chinese warships are operating, generally only when it detects aircraft carriers, as happened last week. A Chinese destroyer and a frigate entered waters to the southwest
The eastern extension of the Taipei MRT Red Line could begin operations as early as late June, the Taipei Department of Rapid Transit Systems said yesterday. Taipei Rapid Transit Corp said it is considering offering one month of free rides on the new section to mark its opening. Construction progress on the 1.4km extension, which is to run from the current terminal Xiangshan Station to a new eastern terminal, Guangci/Fengtian Temple Station, was 90.6 percent complete by the end of last month, the department said in a report to the Taipei City Council's Transportation Committee. While construction began in October 2016 with an
NON-RED SUPPLY: Boosting the nation’s drone industry is becoming increasingly urgent as China’s UAV dominance could become an issue in a crisis, an analyst said Taiwan’s drone exports to Europe grew 41.7-fold from 2024 to last year, with demand from Ukraine’s fight against Russian aggression the most likely driver of growth, a study showed. The Institute for Democracy, Society and Emerging Technology (DSET) in a statement on Wednesday said it found that many of Taiwan’s uncrewed aerial vehicle (UAV) sales were from Poland and the Czech Republic. These countries likely transferred the drones to Ukraine to aid it in its fight against the Russian invasion that started in 2022, it said. Despite the gains, Taiwan is not the dominant drone exporter to these markets, ranking second and fourth
Japanese Prime Minister Sanae Takaichi’s comment last year on Tokyo’s potential reaction to a Taiwan-China conflict has forced Beijing to rewrite its invasion plans, a retired Japanese general said. Takaichi told the Diet on Nov. 7 last year that a Chinese naval blockade or military attack on Taiwan could constitute a “survival-threatening situation” for Japan, potentially allowing Tokyo to exercise its right to collective self-defense. Former Japan Ground Self-Defense Force general Kiyofumi Ogawa said in a recent speech that the remark has been interpreted as meaning Japan could intervene in the early stages of a Taiwan Strait conflict, undermining China’s previous assumptions